abrdn plc Buys 16,811 Shares of The Clorox Company (NYSE:CLX)

abrdn plc grew its holdings in The Clorox Company (NYSE:CLX - Free Report) by 3.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 560,714 shares of the company's stock after acquiring an additional 16,811 shares during the period. abrdn plc owned about 0.45% of Clorox worth $90,956,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in CLX. Wealthcare Advisory Partners LLC acquired a new stake in shares of Clorox in the 1st quarter worth about $242,000. State of Michigan Retirement System boosted its holdings in shares of Clorox by 0.3% during the first quarter. State of Michigan Retirement System now owns 34,051 shares of the company's stock worth $5,214,000 after purchasing an additional 100 shares during the period. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in shares of Clorox by 0.3% during the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 326,479 shares of the company's stock valued at $49,987,000 after acquiring an additional 923 shares in the last quarter. Retirement Guys Formula LLC increased its position in Clorox by 15.3% in the 1st quarter. Retirement Guys Formula LLC now owns 4,061 shares of the company's stock worth $622,000 after purchasing an additional 538 shares during the last quarter. Finally, SpiderRock Advisors LLC bought a new position in Clorox during the first quarter valued at approximately $429,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Down 0.2 %

CLX traded down $0.27 during trading on Wednesday, reaching $156.56. The company had a trading volume of 2,046,717 shares, compared to its average volume of 1,226,938. The business's fifty day moving average price is $161.14 and its 200 day moving average price is $145.90. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09. The company has a market cap of $19.44 billion, a P/E ratio of 81.12, a PEG ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. The business had revenue of $1.90 billion for the quarter, compared to analysts' expectations of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. Equities analysts anticipate that The Clorox Company will post 6.64 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.12%. The ex-dividend date is Wednesday, October 23rd. Clorox's dividend payout ratio is presently 252.85%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CLX shares. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. Citigroup upped their price objective on Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and boosted their target price for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Barclays boosted their price objective on Clorox from $130.00 to $137.00 and gave the stock an "underweight" rating in a report on Friday, October 11th. Finally, DA Davidson reiterated a "neutral" rating and set a $153.00 price target on shares of Clorox in a research report on Friday, September 6th. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $150.14.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company's stock, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.51% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.